Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice—An unbiased functional study

H Hongsup Yoon (Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München) L Lisa Ann Gerdes (Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München) F Florian Beigel (Department of Medicine II, University Hospital, Ludwig-Maximilians-Universität München) Y Yihui Sun (Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco) J Janine Kövilein (Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München) J Jiancheng Wang (Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München) T Tanja Kuhlmann (Institute of Neuropathology, University Hospital Münster) A Andrea Flierl-Hecht (Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München) D Dirk Haller R Reinhard Hohlfeld (Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München) S Sergio E. Baranzini (Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco) H Hartmut Wekerle (Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München) A Anneli Peters (Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München)

Abstract

We developed a two-tiered strategy aiming to identify gut bacteria functionally linked to the development of multiple sclerosis (MS). First, we compared gut microbial profiles in a cohort of 81 monozygotic twins discordant for MS. This approach allowed to minimize confounding effects by genetic and early environmental factors and identified over 50 differently abundant taxa with the majority of increased taxa within the Firmicutes . These included taxa previously described to be associated with MS ( Anaerotruncus colihominis and Eisenbergiella tayi ), along with newly identified taxa, such as Copromonas and Acutalibacter . Second, we interrogated the intestinal habitat and functional impact of individual taxa on the development of MS-like disease. In an exploratory approach, we enteroscopically sampled microbiota from different gut segments of selected twin pairs and compared their compositional profiles. To assess their functional potential, samples were orally transferred into germfree transgenic mice prone to develop spontaneous MS-like experimental autoimmune encephalomyelitis (EAE) upon bacterial colonization. We found that MS-derived ileal microbiota induced EAE at substantially higher rates than analogous material from healthy twin donors. Furthermore, female mice were more susceptible to disease development than males. The likely active organisms were identified as Eisenbergiella tayi and Lachnoclostridium, members of the Lachnospiraceae family. Our results identify potentially disease-facilitating bacteria sampled from the ileum of MS affected twins. The experimental strategy may pave the way to functionally understand the role of gut microbiota in initiation of MS.

Article Details

Volume / Issue Vol. 122, Issue 18
Published May 06, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (13)

H

Hongsup Yoon

Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München

L

Lisa Ann Gerdes

Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München

F

Florian Beigel

Department of Medicine II, University Hospital, Ludwig-Maximilians-Universität München

Y

Yihui Sun

Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco

J

Janine Kövilein

Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München

J

Jiancheng Wang

Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München

T

Tanja Kuhlmann

Institute of Neuropathology, University Hospital Münster

A

Andrea Flierl-Hecht

Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München

D

Dirk Haller

R

Reinhard Hohlfeld

Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München

S

Sergio E. Baranzini

Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco

H

Hartmut Wekerle

Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München

A

Anneli Peters

Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München